/ /

  • linkedin
  • Increase Font
  • Sharebar

    MIGS driving the device market

     

    Transcend Medical

    The eye is one of the few organs in which stenting has not become standard of care. Neurovascular, cardiovascular, pulmonary, gastrointestinal, urological/gynecological, peripheral--the list for stenting procedures is long and growing.

    “Stents are common across many other specialties,” said Sean Ianchulev, MD, MPH, chief medical officer and vice president of business development. “I am very happy to see that stent technology is finally coming to ophthalmology.”

    Transcend is moving toward market with its CyPass Micro-Stent that drains into the suprachoroidal space. The suprachoroidal space is a compelling surgical target, he said. It is a large, continuous space that can be accessed through a single entry point.

    “A single stent creates a permanent conduit for aqueous egress,” he said. “Using the suprachoroidal space creates significant advantages for outflow. It has negative pressure gradient, which drives egress and we can access that space in a very atraumatic way.”

    Two-year data from the European Union shows a mean reduction in IOP of 35% with phaco and 32% as a stand-alone procedure with no significant safety concerns. In the United States, the pivotal COMPASS trial completed enrollment with initial results expected in 2015.

    “Conventional glaucoma surgery can have some very significant complications,” Dr. Ianchulev said. “We are trying to move toward phaco surgical standards with a procedure that is both highly effective and highly safe for patients.”

    New Call-to-action

    0 Comments

    You must be signed in to leave a comment. Registering is fast and free!

    All comments must follow the ModernMedicine Network community rules and terms of use, and will be moderated. ModernMedicine reserves the right to use the comments we receive, in whole or in part,in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

    • No comments available

    Poll

    View Results